Classification of Packaging Changes
![Design Controls for Drug-Device Combination Products - Live Online Training](files/eca/userImages/training.img/Z-ECA-Design-Controls-Drug-Device-Combination-2024-Live-Online-Training.jpg)
Recommendation
15/16 October 2024
How to ensure GMP compliant Development and LIfe-Cycle-Management for Drug-Device Combination Products
Prior to submission of a variation whose classification is not provided for in Commission Regulation (EC) 1234/2008, a Marketing Authorization Holder (MAH) or a competent authority of a Member State may request the CMDh (Co-ordination group for Mutual recognition and Decentralized procedures – human) or the EMA (for centralized procedures) to provide a recommendation on the classification of the proposed change ("Article 5 Recommendations").
Classification of unforeseen packaging variations
Recommendations regarding packaging changes are listed for APIs (e.g. for deletion of one of the authorized bulk or final containers, change of a secondary packaging component of the drug substance) and for finished products (e.g. change in the name of a supplier of a packaging component). Details on testing frequency for packaging material are seen as a GMP issue; therefore all the detailed information on testing frequency for packaging material in the dossier (Module 3) should be deleted via a Type IB variation.
Recently, the CMDh added a recommendation for the classification of the proposed change “total thickness” for the blister foil of the primary packaging material for a solid dosage form (specification widened due to a difference in grammage of the primer material). According to the CMDh this change should be submitted as a type IA variation under B.II.e.2.z. However, the following conditions apply:
- The material of the primer is not changed,
- Stability studies have been started under ICH conditions in at least two pilot scale or industrial scale batches. These studies must be finalized and data will be provided immediately to the competent authorities if out of specifications (OOS) results or potentially OOS results occur.
For more information please see the CMDh Recommendation for classification of unforeseen variations according to Article 5 of Commission Regulation (EC) 1234/2008.
Related GMP News
23.07.2024New Ph. Eur. Chapter on Elemental Impurities in Plastic Materials
17.07.2024USP Proposal for Elastomeric Packaging Components
10.07.2024USP Proposal for Metallic Packaging Systems
05.06.2024Requirements for Sterile Packaging Material
14.03.2024New USP Chapter on Cured Silicone Components
07.12.2023First Electronic Product Information (ePI) for Human Medicines